CAD 0.07
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 8.17 Million CAD | 85.48% |
2022 | 4.4 Million CAD | 30.5% |
2021 | 3.37 Million CAD | 389.25% |
2020 | 690.68 Thousand CAD | 0.0% |
2019 | - CAD | -100.0% |
2018 | 523.4 Thousand CAD | 4987.06% |
2017 | 10.28 Thousand CAD | 0.0% |
2016 | - CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q3 | 3.05 Million CAD | -10.68% |
2024 Q2 | 3.41 Million CAD | 6.61% |
2024 Q1 | 3.2 Million CAD | 23.48% |
2023 Q2 | 2.17 Million CAD | 83.09% |
2023 Q1 | 1.18 Million CAD | 30.13% |
2023 FY | 8.17 Million CAD | 85.48% |
2023 Q4 | 2.59 Million CAD | 16.66% |
2023 Q3 | 2.22 Million CAD | 2.28% |
2022 Q4 | 912.56 Thousand CAD | -24.12% |
2022 Q3 | 1.2 Million CAD | 5.01% |
2022 Q2 | 1.14 Million CAD | -0.35% |
2022 Q1 | 1.14 Million CAD | -13.99% |
2022 FY | 4.4 Million CAD | 30.5% |
2021 FY | 3.37 Million CAD | 389.25% |
2021 Q2 | 130.51 Thousand CAD | -89.61% |
2021 Q3 | 655.86 Thousand CAD | 402.52% |
2021 Q4 | 1.33 Million CAD | 103.74% |
2021 Q1 | 1.25 Million CAD | 433.66% |
2020 Q4 | 235.46 Thousand CAD | 0.0% |
2020 Q1 | 350 Thousand CAD | 0.0% |
2020 Q2 | 105.21 Thousand CAD | -69.94% |
2020 FY | 690.68 Thousand CAD | 0.0% |
2020 Q3 | - CAD | -100.0% |
2019 Q3 | - CAD | 0.0% |
2019 FY | - CAD | -100.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 Q1 | - CAD | -100.0% |
2018 Q1 | 30.23 Thousand CAD | -74.75% |
2018 Q2 | 10.28 Thousand CAD | -65.97% |
2018 FY | 523.4 Thousand CAD | 4987.06% |
2018 Q3 | 16.15 Thousand CAD | 57.05% |
2018 Q4 | 5377.00 CAD | -66.72% |
2017 FY | 10.28 Thousand CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q4 | 119.76 Thousand CAD | 0.0% |
2016 FY | - CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Aion Therapeutic Inc. | 367.47 Thousand CAD | -2125.872% |
Ayurcann Holdings Corp. | 25.15 Million CAD | 67.487% |
Blueberries Medical Corp. | 288.27 Thousand CAD | -2737.464% |
The BC Bud Corporation | 61.48 Thousand CAD | -13204.079% |
BioNxt Solutions Inc. | 372.24 Thousand CAD | -2097.362% |
CordovaCann Corp. | 13.59 Million CAD | 39.832% |
Christina Lake Cannabis Corp. | 11.77 Million CAD | 30.562% |
Captor Capital Corp. | 36.76 Million CAD | 77.752% |
City View Green Holdings Inc. | 8582.00 CAD | -95211.279% |
1CM Inc. | 35.34 Million CAD | 76.855% |
Global Hemp Group Inc. | - CAD | -Infinity% |
Greenway Greenhouse Cannabis Corporation | 5.23 Million CAD | -56.392% |
IM Cannabis Corp. | 48.8 Million CAD | 83.24% |
Lobe Sciences Ltd. | 840.53 Thousand CAD | -873.145% |
Maple Leaf Green World Inc. | - CAD | -Infinity% |
Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -13532.69% |
Ovation Science Inc. | 61.93 Thousand CAD | -13106.985% |
Pharmadrug Inc. | - CAD | -Infinity% |
Captiva Verde Wellness Corp. | 174.78 Thousand CAD | -4579.761% |
RAMM Pharma Corp. | 5.06 Million CAD | -61.485% |
RIV Capital Inc. | 7.48 Million CAD | -9.235% |
Revive Therapeutics Ltd. | - CAD | -Infinity% |
Red White & Bloom Brands Inc. | 88.33 Million CAD | 90.74% |
SLANG Worldwide Inc. | 35.68 Million CAD | 77.076% |
1933 Industries Inc. | 18.27 Million CAD | 55.237% |
Red Light Holland Corp. | 4.75 Million CAD | -72.131% |
Top Strike Resources Corp. | 13.32 Million CAD | 38.625% |
Xebra Brands Ltd. | 106.85 Thousand CAD | -7554.872% |
Adastra Holdings Ltd. | 22.22 Million CAD | 63.192% |